Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia

SARS-CoV-2 has infected millions of people worldwide, but little is known at this time about second infections or reactivation. Here, we report a case of a 55-year-old female undergoing treatment for CD20+ B cell acute lymphoblastic leukemia who experienced a viral reactivation after receiving ritux...

Descripción completa

Detalles Bibliográficos
Autores principales: Lancman, Guido, Mascarenhas, John, Bar-Natan, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531062/
https://www.ncbi.nlm.nih.gov/pubmed/33008453
http://dx.doi.org/10.1186/s13045-020-00968-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531062/
https://www.ncbi.nlm.nih.gov/pubmed/33008453
http://dx.doi.org/10.1186/s13045-020-00968-1

Ejemplares similares